Hemopurifier, a blood filtration device, is showing promising early results in an Australian oncology trial, with reductions in harmful particles and positive immune biomarker changes. The platform has potential applications in cancer, infectious diseases, and long COVID, supported by a strengthened financial position and a focus on disciplined execution.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.